Axcella Health Inc. Common Stock
AXLA
AXLA was delisted on the 22nd of November, 2023.
35 hedge funds and large institutions have $71.6M invested in Axcella Health Inc. Common Stock in 2021 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 4 increasing their positions, 16 reducing their positions, and 5 closing their positions.
203% more call options, than puts
Call options by funds: $209K | Put options by funds: $69K
8% less funds holding
Funds holding: 38 → 35 (-3)
26% less capital invested
Capital invested by funds: $97.3M → $71.6M (-$25.7M)
60% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 5
75% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 16
100% less funds holding in top 10
Funds holding in top 10: 2 → 0 (-2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$234K |
| 2 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$111K |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$86.2K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$12.4K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$5.14K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$370K |
| 2 |
First Trust Advisors
Wheaton,
Illinois
|
-$181K |
| 3 |
Millennium Management
New York
|
-$159K |
| 4 |
ECM
ExodusPoint Capital Management
New York
|
-$134K |
| 5 |
Marshall Wace
London,
United Kingdom
|
-$111K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
Barclays
London,
United Kingdom
| $7K | -$2.91K | -34 | -27% |
|
27
Morgan Stanley
New York
| $5K | -$2.23K | -26 | -27% |
|
28
First Manhattan
New York
| $5K | – | – | – |
|
29
Wells Fargo
San Francisco,
California
| $3K | -$86 | -1 | -2% |
|
|
TRCT
30
Tower Research Capital (TRC)
New York
| $3K | +$3.08K | +36 | New |
|
31
Bank of America
Charlotte,
North Carolina
| $2K | -$9.17K | -107 | -80% |
|
|
APA
32
American Portfolios Advisors
Holbrook,
New York
| $1.19K | – | – | – |
|
33
JP Morgan Chase
New York
| $1K | -$4.71K | -55 | -87% |
|
|
GRP
34
Global Retirement Partners
San Rafael,
California
| $1K | – | – | – |
|
35
BNP Paribas Financial Markets
Paris,
France
| $977 | -$257 | -3 | -19% |
|
|
36
First Trust Advisors
Wheaton,
Illinois
| – | -$181K | -1,801 | Closed |
|
|
ECM
37
ExodusPoint Capital Management
New York
| – | -$134K | -1,337 | Closed |
|
38
Charles Schwab
San Francisco,
California
| – | -$42K | -412 | Closed |
|
39
Royal Bank of Canada
Toronto,
Ontario, Canada
| – | -$18K | -184 | Closed |
|
AXLA Hedge Fund Activity: Q3 2021 in Review
35 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Axcella Health Inc. Common Stock (AXLA) for Q3 2021, worth a combined $71.6M — down 26% from $97.3M a quarter earlier.
Sellers outnumbered buyers: 5 funds closed out of AXLA and 2 opened new positions — a net loss of 3 holders — while 16 trimmed existing stakes and 4 added.
The largest buyer was Fidelity Investments, adding an estimated $234K. The largest seller was Renaissance Technologies, cutting an estimated $370K.
- 35 institutional investors held Axcella Health Inc. Common Stock (AXLA) as of Q3 2021, down from 38 in Q2 2021.
- Funds reported $71.6M of Axcella Health Inc. Common Stock stock for Q3 2021, down 26% quarter-over-quarter.
- 2 funds opened new Axcella Health Inc. Common Stock positions in Q3 2021 and 5 closed out, a net change of -3 holders.
- The largest Axcella Health Inc. Common Stock buyer in Q3 2021 was Fidelity Investments, an estimated $234K added.
- The largest Axcella Health Inc. Common Stock seller in Q3 2021 was Renaissance Technologies, an estimated $370K sold.
Based on aggregated 13F filings for Q3 2021.